158 related articles for article (PubMed ID: 16179901)
1. Low-molecular-weight heparin and survival in patients with malignant disease.
Kakkar AK
Cancer Control; 2005 Sep; 12 Suppl 1():22-30. PubMed ID: 16179901
[No Abstract] [Full Text] [Related]
2. Does low-molecular-weight heparin influence cancer-related mortality?
Meyer G
Ann Oncol; 2007 Mar; 18(3):609-10. PubMed ID: 17322543
[No Abstract] [Full Text] [Related]
3. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
Schulman S
Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
[No Abstract] [Full Text] [Related]
4. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
Caine GJ; Lip GY
Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
[No Abstract] [Full Text] [Related]
5. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
Ageno W; Squizzato A
Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
[No Abstract] [Full Text] [Related]
7. International normalized ratio and anticoagulation.
Theerman MR
Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971
[No Abstract] [Full Text] [Related]
8. [Treatment of venous thrombosis in a cancer patient].
Lepäntalo A
Duodecim; 2015; 131(7):637-44. PubMed ID: 26233981
[TBL] [Abstract][Full Text] [Related]
9. [Spontaneous deep venous thrombosis. First symptom of a neoplasm?].
Bischoff A
MMW Fortschr Med; 2007 May; 149(22):16. PubMed ID: 18074457
[No Abstract] [Full Text] [Related]
10. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: reply.
Sanford D; Lazo-Langner A
J Thromb Haemost; 2014 Sep; 12(9):1574-5. PubMed ID: 25039759
[No Abstract] [Full Text] [Related]
11. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: comment.
Tardy B; Chalayer E; Chapelle C; Mismetti P
J Thromb Haemost; 2014 Sep; 12(9):1572-3. PubMed ID: 24976020
[No Abstract] [Full Text] [Related]
12. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
[No Abstract] [Full Text] [Related]
13. Management of deep vein thrombosis in cancer patients.
Jahanzeb M
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
[No Abstract] [Full Text] [Related]
14. Should patients with venous thromboembolism and cancer be treated differently?
Smorenburg SM; Hutten BA; Prins MH
Haemostasis; 1999 Dec; 29 Suppl S1():91-7. PubMed ID: 10629414
[TBL] [Abstract][Full Text] [Related]
15. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
Lee AY
Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
[No Abstract] [Full Text] [Related]
16. Clots and cancer.
Ali SN; Stebbing J; Mazhar D
Future Oncol; 2006 Dec; 2(6):647-9. PubMed ID: 17155891
[No Abstract] [Full Text] [Related]
17. Thromboembolism.
Fitzmaurice D; Hobbs FD; McManus R
Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
[No Abstract] [Full Text] [Related]
18. Low-molecular-weight heparin for deep venous thrombosis.
Bielanski TE
J Fam Pract; 1999 Sep; 48(9):661-2. PubMed ID: 10498065
[No Abstract] [Full Text] [Related]
19. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
Levine M
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
[TBL] [Abstract][Full Text] [Related]
20. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials.
Sanford D; Naidu A; Alizadeh N; Lazo-Langner A
J Thromb Haemost; 2014 Jul; 12(7):1076-85. PubMed ID: 24796727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
